Publications
2,495
Citations
129,843
Est. group size
~4
Recurring co-author estimate
Active years
26
Publishing since 2001
Typically publishes in teams of ~17 · 1% small-team papers (≤3 authors) · across 139 venues
- Tertiary lymphoid structures harbour stem-like tumour-specific T cells
Nature · 2026
- Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells
Nature Biotechnology · 2026
- Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
New England Journal of Medicine · 2026
- Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma
Journal for ImmunoTherapy of Cancer · 2026
- Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Nature · 2026
- Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
Nature Medicine · 2026
- Figure S3 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Table S14 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Table S1 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Figure S10 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Figure S4 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Table S4 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Figure S8 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Figure S7 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Table S2 from Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
2026
- Journal of Clinical Oncology×466
- Annals of Oncology×113
- European Urology×50
- The Journal of Urology×48
- The Oncologist×48
- Megan Hinkley
Medicine · The Ohio State University
- Ulka N. Vaishampayan
Medicine · University of Michigan
- Taylor Goodstein
Medicine · The Ohio State University
- Elshad Hasanov
Medicine · The Ohio State University
- Theodore F. Logan
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile